ClinicalTrials.gov
ClinicalTrials.gov Menu

Anti-Retrovirals for Kaposi's Sarcoma (ARKS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00444379
Recruitment Status : Completed
First Posted : March 7, 2007
Last Update Posted : August 20, 2014
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Gilead Sciences
Abbott
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : February 2012
  Actual Study Completion Date : July 2012